Hosted on MSN
Why Eli Lilly is the IBD stock of the day — again — as its Novo Nordisk rivalry deepens
Eli LillyLLY is Wednesday's IBD Stock Of The Day. Despite a steep rivalry with Novo NordiskNVO, which has already launched a weight-loss pill, Lilly shares are bounding off their 50-day line with a ...
26don MSN
Novo Nordisk’s Wegovy head start on pills forces investors to rethink Eli Lilly's GLP-1 dominance
Early signs from the launch of Novo Nordisk's Wegovy pill and Eli Lilly & Co.'s Foundayo are making investors rethink the opportunity for GLP-1 pills.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results